2 top experts resigned from a key panel after the FDA approved a new Alzheimer’s drug

Hello,

Welcome to Insider Healthcare. I’m Lydia Ramsey Pflanzer, and today in healthcare news:


If you’re new to this newsletter, sign up here. Comments, tips? Email me at [email protected] or tweet @lydiaramsey125. Let’s get to it…


FDA
FDA Andrew Harnik/AP Photo

Two doctors have resigned from a prestigious panel after FDA approved a controversial Alzheimer’s drug

Get the scoop here>>


Amazon Pharmacy

Amazon and Walmart are competing to offer you the cheapest prescriptions, and it could shake up the entire pharmacy industry

Find out more>>


Lee and Glen
Glen Tullman, ‘s former CEO, and Lee Shapiro, an original investor, celebrate during the company’s initial public offering in 2019. Livongo

A startup backed by Livongo veterans just got a nearly $500 million valuation, and it’s coming for healthcare’s middlemen

Read the full exclusive here>>


More stories we’re reading:


– Lydia